drugset / Trial / NCT01156844

Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol

NCT01156844

Phase 2 Completed 191 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study assessed the bronchodilator efficacy of three different regimens of indacaterol in patients with asthma

Timeline

Start
2010-03
Primary completion
2010-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Indacaterol Other / unclassified 37.5 ug Inhaled
Subject Indacaterol Other / unclassified 75 ug Inhaled
Subject Indacaterol Other / unclassified 150 ug Inhaled

Indications